Search research articles
Contact Us
Filters
Showing results (61-70 of 301) with videos related to
Page
of 31
Sort By:
Circulation Research
|
March 20, 2010
Circadian clocks and vascular function
Georgios K Paschos, Garret A FitzGerald
Bio-Protocol
|
July 23, 2016
Insulin Tolerance Test and Hyperinsulinemic-Euglycemic Clamp
Georgios K Paschos, Garret A FitzGerald
Annals of Medicine
|
April 19, 2007
Central and peripheral clocks in cardiovascular and metabolic function
Anne M Curtis, Garret A Fitzgerald
Nature Medicine
|
December 8, 2011
Efficient drug approval and monitoring must rely on sound regulatory science
Emma A Meagher, Garret A Fitzgerald
Trends in Genetics : TIG
|
August 29, 2017
Circadian Clocks and Metabolism: Implications for Microbiome and Aging
Georgios K Paschos, Garret A FitzGerald
Circulation Research
|
May 26, 2022
Endothelial Tenascin-X Is Going With the Flow
Soon Yew Tang, Garret A FitzGerald
Advances in Biological Regulation
|
July 24, 2021
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Emanuela Ricciotti, Krzysztof Laudanski, Garret A FitzGerald
Science (New York, N.Y.)
|
September 5, 2020
Reopening schools during COVID-19
Ronan Lordan, Garret A FitzGerald, Tilo Grosser
The Journal of Clinical Investigation
|
January 6, 2006
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
Tilo Grosser, Susanne Fries, Garret A FitzGerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Page
of 31
Search research articles
Search
Showing results (61-70 of 301) with videos related to
Sort By:
Page
of 31
Circulation Research
|
March 20, 2010
Circadian clocks and vascular function
Georgios K Paschos, Garret A FitzGerald
Bio-Protocol
|
July 23, 2016
Insulin Tolerance Test and Hyperinsulinemic-Euglycemic Clamp
Georgios K Paschos, Garret A FitzGerald
Annals of Medicine
|
April 19, 2007
Central and peripheral clocks in cardiovascular and metabolic function
Anne M Curtis, Garret A Fitzgerald
Nature Medicine
|
December 8, 2011
Efficient drug approval and monitoring must rely on sound regulatory science
Emma A Meagher, Garret A Fitzgerald
Trends in Genetics : TIG
|
August 29, 2017
Circadian Clocks and Metabolism: Implications for Microbiome and Aging
Georgios K Paschos, Garret A FitzGerald
Circulation Research
|
May 26, 2022
Endothelial Tenascin-X Is Going With the Flow
Soon Yew Tang, Garret A FitzGerald
Advances in Biological Regulation
|
July 24, 2021
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Emanuela Ricciotti, Krzysztof Laudanski, Garret A FitzGerald
Science (New York, N.Y.)
|
September 5, 2020
Reopening schools during COVID-19
Ronan Lordan, Garret A FitzGerald, Tilo Grosser
The Journal of Clinical Investigation
|
January 6, 2006
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
Tilo Grosser, Susanne Fries, Garret A FitzGerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Page
of 31